A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to CTCL
Related studies linked through entity extraction aliases.
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
- Status
- RECRUITING
- Phase
- PHASE3
Ritlecitinib in CTCL
- Status
- TERMINATED
- Phase
- PHASE2
A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL)
- Status
- COMPLETED
- Phase
- PHASE1
StrataCTX® as a Steroid Sparing Device
- Status
- RECRUITING
- Phase
- NA
Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph1 Volasertib Plus Romidepsin in R/R PTCL and CTCL
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of MEDI9197 in Subjects With Solid Tumors or CTCL and in Combination With Durvalumab and/or Palliative Radiation in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1